Study of the frequency of HLA-DRB1 alleles in Brazilian patients with rheumatoid arthritis

Revista Brasileira de Reumatologia

Volumn 51, Issue 5, 2011, Pages 465-483

  Usnayo, Magali Justina Gómez ^a   Andrade, Luis Eduardo Coelho ^b   Alarcon, Renata Triguenho ^b   Oliveira, Juliana Cardoso ^a   Silva, Gustavo Milson Fabrício ^a   Bendet, Izidro ^c   Burlingame, Rufus ^d   Porto, Luis Cristóvão ^a   Pinheiro, Geraldo da Rocha Castelar ^a  

^a STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c UERJ ^*  (Brazil)

^d INOVA DIAGNOSTICS INC   (United States)

Author keywords

Genetic polymorphism; HLA DRB1; Immunogenetics; Rheumatoid arthritis; Shared epitope

Indexed keywords

AUTOANTIBODY; CITRULLINATED PEPTIDE ANTIBODY; UNCLASSIFIED DRUG; HLA DRB1 ANTIGEN;

ADULT; ARTICLE; BRAZIL; CASE CONTROL STUDY; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC RISK; GENETIC SUSCEPTIBILITY; HLA DRB1 GENE; HUMAN; MAJOR CLINICAL STUDY; MALE; RHEUMATOID ARTHRITIS; ADOLESCENT; ALLELE; GENETICS; MIDDLE AGED;

ADOLESCENT; ADULT; ALLELES; ARTHRITIS, RHEUMATOID; BRAZIL; CASE-CONTROL STUDIES; FEMALE; HLA-DRB1 CHAINS; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 80053208257     PISSN: 04825004     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Senna ER, de Barros AL, Silva EO, Costa IF, Pereira LV, Ciconelli RM et al. Prevalence of rheumatic diseases in Brazil: a study using the COPCORD approach. J Rheumatol 2004; 31(3):594-7.
2. Pinheiro GRC. Artrite reumatoide. In: Moreira C, Pinheiro GRC, Marques Neto JF (eds.). Reumatologia Essencial. Rio de Janeiro: Guanabara Koogan; 2009. p. 338-54.
3. Hochberg MC, Silman AJ, Smolen JS, Weinblatt ME, Weisman MH. Rheumatology. 4ed. Philadelphia: Mosby; 2008.
4. MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum 2000; 43(1):30-7.
5. Bowes J, Barton A. Recent advances in the genetics of RA susceptibility. Rheumatology (Oxford) 2008; 47(4):399-402.
6. Gregersen PK, Silver J, Winchester RJ. The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum 1987; 30(11):1205-13.
7. Klareskog L, Stolt P, Lundberg K, Kallberg H, Bengtsson C, Grunewald J et al. A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination. Arthritis Rheum 2006; 54(1):38-46.
8. Weyand CM XC, Goronzy JJ. Homozygosity for the HLA-DRB1 allele selects for extra-articular manifestations in rheumatoid arthritis. J Clin Invest 1992; 89(6):2033-9.
9. Weyand CM, Goronzy JJ. Inherited and noninherited risk factors in rheumatoid arthritis. Curr Opin Rheumatol 1995; 7(3):206-13.
10. Massardo L, Gareca N, Cartes MA, Cervilla V, Gonzalez A, Jacobelli S. The presence of the HLA-DRB1 shared epitope correlates with erosive disease in Chilean patients with rheumatoid arthritis. Rheumatology (Oxford) 2002; 41(2):153-6.
11. Morgan AW, Haroon-Rashid L, Martin SG, Gooi HC, Worthington J, Thomson W et al. The shared epitope hypothesis in rheumatoid arthritis: evaluation of alternative classification criteria in a large UK Caucasian cohort. Arthritis Rheum 2008; 58(5):1275-83.
12. Gonzalez-Gay MA, Garcia-Porrua C, Hajeer AH. Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis. Semin Arthritis Rheum 2002; 31(6):355-60.
13. Lee HS, Lee KW, Song GG, Kim HA, Kim SY, Bae SC. Increased susceptibility to rheumatoid arthritis in Koreans heterozygous for HLA-DRB1*0405 and *0901. Arthritis Rheum 2004; 50(11):3468-75.
14. Wakitani S, Murata N, Toda Y, Ogawa R, Kaneshige T, Nishimura Y et al. The relationship between HLA-DRB1 alleles and disease subsets of rheumatoid arthritis in Japanese. Br J Rheumatol 1997; 36(6):630-6.
15. de Vries N, Ronningen KS, Tilanus MG, Bouwens-Rombouts A, Segal R, Egeland T et al. HLA-DR1 and rheumatoid arthritis in Israeli Jews: sequencing reveals that DRB1*0102 is the predominant HLA-DR1 subtype. Tissue Antigens 1993; 41(1):26-30.
16. Boki KA, Panayi GS, Vaughan RW, Drosos AA, Moutsopoulos HM, Lanchbury JS. HLA class II sequence polymorphisms and susceptibility to rheumatoid arthritis in Greeks. The HLA-DR beta shared-epitope hypothesis accounts for the disease in only a minority of Greek patients. Arthritis Rheum 1992; 35(7):749-55.
17. Templin DW, Boyer GS, Lanier AP, Nelson JL, Barrington RA, Hansen JA et al. Rheumatoid arthritis in Tlingit Indians: clinical characterization and HLA associations. J Rheumatol 1994; 21(7):1238-44.
18. Castro F, Acevedo E, Ciusani E, Angulo JA, Wollheim FA, Sandberg-Wollheim M. Tumour necrosis factor microsatellites and HLA-DRB1*, HLA-DQA1*, and HLA-DQB1* alleles in Peruvian patients with rheumatoid arthritis. Ann Rheum Dis 2001; 60(8):791-5.
19. Arias MV, Domingues EV, Lozano RB, Flores CV, Peralta MM, Salinas CZ. Study of class I and II HLA alleles in 30 Ecuadorian patients with rheumatoid arthritis compared with alleles from healthy and affected subjects with other rheumatic diseases. Rev Bras Reumatol 2010; 50(4):423-33.
20. Anaya JM, Correa PA, Mantilla RD, Arcos-Burgos M. Rheumatoid arthritis association in Colombian population is restricted to HLA-DRB1*04 QRRAA alleles. Genes Immun 2002; 3(1):56-8.
21. Citera G, Padulo LA, Fernandez G, Lazaro MA, Rosemffet MG, Maldonado Cocco JA. Influence of HLA-DR alleles on rheumatoid arthritis: susceptibility and severity in Argentine patients. J Rheumatol 2001; 28(7):1486-91.
22. Bertolo MB, Costallat LTL, Persoli LB, Costa FF. Alelos HLA-DRB1 e prognóstico da artrite reumatoide em pacientes brasileiros. Rev Bras Reumatol 2001; 41(3):151-6.
23. Louzada-Junior P, Freitas MVC, Oliveira RDR, Deghaide NHS, Conde RA, Bertolo MB et al. A majority of Brazilian patients with rheumatoid arthritis HLA-DRB1 alleles carry both the HLA-DRB1 shared epitope and anti-citrullinated peptide antibodies. Braz J Med Biol Res 2008; 41(6):493-9.
24. van der Helm-van Mil AH, Huizinga TW, Schreuder GM, Breedveld FC, de Vries RR, Toes RE. An independent role of protective HLA class II alleles in rheumatoid arthritis severity and susceptibility. Arthritis Rheum 2005; 52(9):2637-44.
25. Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Menard HA et al. The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies. Arthritis Rheum 2009; 60(3):698-707.
26. Bukhari M, Lunt M, Harrison BJ, Scott DG, Symmons DP, Silman AJ. Erosions in inflammatory polyarthritis are symmetrical regardless of rheumatoid factor status: results from a primary carebased inception cohort of patients. Rheumatology (Oxford) 2002; 41(3):246-52.
27. Meyer O, Labarre C, Dougados M, Goupille P, Cantagrel A, Dubois A et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003; 62(2):120-6.
28. Mattey DL, Dawes PT, Clarke S, Fisher J, Brownfield A, Thomson W et al. Relationship among the HLA-DRB1 shared epitope, smoking, and rheumatoid factor production in rheumatoid arthritis. Arthritis Rheum 2002; 47(4):403-7.
29. Irigoyen P, Lee AT, Wener MH, Li W, Kern M, Batliwalla F et al. Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles. Arthritis Rheum 2005; 52(12):3813-8.
30. Orozco G, Pascual-Salcedo D, Lopez-Nevot MA, Cobo T, Cabezon A, Martin-Mola E et al. Auto-antibodies, HLA and PTPN22: susceptibility markers for rheumatoid arthritis. Rheumatology (Oxford) 2008; 47(2):138-41.
31. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Huizinga TW, Toes RE, de Vries RR. The HLA-DRB1 shared epitope alleles are primarily a risk factor for anti-cyclic citrullinated peptide antibodies and are not an independent risk factor for development of rheumatoid arthritis. Arthritis Rheum 2006; 54(4):1117-21.
32. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009; 373(9664):659-72.
33. Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31(3):315-24.
34. Stastny P. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N Engl J Med 1978; 298(16):869-71.
35. Vignal C, Bansal AT, Balding DJ, Binks MH, Dickson MC, Montgomery DS et al. Genetic association of the major histocompatibility complex with rheumatoid arthritis implicates two non-DRB1 loci. Arthritis Rheum 2009; 60(1):53-62.
36. Wakitani S, Imoto K, Murata N, Toda Y, Ogawa R, Ochi T. The homozygote of HLA-DRB1*0901, not its heterozygote, is associated with rheumatoid arthritis in Japanese. Scand J Rheumatol 1998; 27(5):381-2.
37. van der Helm-van Mil AH, Huizinga TW. Advances in the genetics of rheumatoid arthritis point to subclassification into distinct disease subsets. Arthritis Res Ther 2008; 10(2):205.
38. Balsa A, Cabezon A, Orozco G, Cobo T, Miranda-Carus E, Lopez-Nevot MA et al. Influence of HLA-DRB1 alleles in the susceptibility of rheumatoid arthritis and the regulation of antibodies against citrullinated proteins and rheumatoid factor. Arthritis Res Ther 2010; 12(2):R62.
39. Gonzalez A, Nicovani S, Massardo L, Aguirre V, Cervilla V, Lanchbury JS et al. Influence of the HLA-DR beta shared epitope on susceptibility to and clinical expression of rheumatoid arthritis in Chilean patients. Ann Rheum Dis 1997; 56(3):191-3.
40. Teller K, Budhai L, Zhang M, Haramati N, Keiser HD, Davidson A. HLA-DRB1 and DQB typing of Hispanic American patients with rheumatoid arthritis: the "shared epitope" hypothesis may not apply. J Rheumatol 1996; 23(8):1363-8.
41. del Rincon I, Escalante A. HLA-DRB1 alleles associated with susceptibility or resistance to rheumatoid arthritis, articular deformities, and disability in Mexican Americans. Arthritis Rheum 1999; 42(7):1329-38.
42. da Mota LM, dos Santos Neto LL, Burlingame R, Menard HA, Laurindo IM. Laboratory characteristics of a cohort of patients with early rheumatoid arthritis. Rev Bras Reumatol 2010; 50(4):375-88.
43. da Mota LM, Cruz BA, Brenol CV, Pereira IA, Fronza LS, Bertolo MB et al. 2011 Consensus of the Brazilian Society of Rheumatology for diagnosis and early assessment of rheumatoid arthritis. Rev Bras Reumatol 2011; 51(3):199-219.